Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Signal Transduction and Targeted Therapy (1)
British Journal of Cancer (1)
Communications Biology (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (3)

Subject Check one or more subjects to show results from those subjects only.

Cancer
Cell biology
Diseases
Medical research
Oncology

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–3 of 3 results

Advanced filters: Author: Xinfang Hou Clear advanced filters

Efficacy and safety of garsorasib in patients with KRAS G12C-mutated advanced pancreatic cancer

Noboru Yamamoto
Dong Yan
Rui-Hua Xu
Research04 Dec 2025
British Journal of Cancer

Volume: 134, P: 457-462
Garsorasib, a KRAS G12C inhibitor, with or without cetuximab, an EGFR antibody, in colorectal cancer cohorts of a phase II trial in advanced solid tumors with KRAS G12C mutation

Dan-Yun Ruan
Hao-Xiang Wu
Rui-Hua Xu
ResearchOpen Access17 Jun 2025
Signal Transduction and Targeted Therapy

Volume: 10, P: 1-9
Skp2-mediated MLKL degradation confers cisplatin-resistant in non-small cell lung cancer cells

The E3 ligase Skp2 influences the levels of necroptosis regulator MLKL, and Skp2-inhibition sensitizes non-small cell lung cancer (NSCLC) cells to cisplatin in vitro and in vivo, suggesting Skp2 as a therapeutic target to overcome NSCLC chemoresistance.

Huiling Zhou
Li Zhou
Haidan Liu
ResearchOpen Access02 Aug 2023
Communications Biology

Volume: 6, P: 1-14